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EPIDURAL SPINAL CORD COMPRESSION FROM
METASTATIC CANCER: CLINICAL FEATURES AND
MANAGEMENT
Pages with reference to book, From 60 To 62

Hina Shaheen, Saleem Abubakar, Imtiaz Malik, Irfan Altafullah, Feroz Alam, Ata Khan ( Department of Medicine, The Aga
Khan University Hospital, Karachi. )

ABSTRACT
We retrospectively analyzed thirty-three patients (21 males, 12 females) with malignancy induced
spinal cord compression (SCC). The mean age of the patients was 42.8 years and almost half (51%) of
them presented with SCC. Mean duration of symptoms was 4.5 months and the mean interval between
the original diagnosis of cancer and the development of SCC was 14.6 months. Back pain was the most
frequent (97%) symptom with an equal number of patients having subjective or objective evidence of
lower limb weakness. Majority (73%) of the patients were non-ambulatory at the time of diagnosis.
Spinal level involvement was mostly thoracic (62%) followed by lumber (38%). Breast cancer was the
commonest underlying malignancy (21%). Lung (12%), prostrate (12%), multiple myeloma (9%), and
carcinoma with unknown primary (12%) were also frequently encountered. There was an overall
response rate of 22% to the therapeutic interventions: mostly observed in the ambulatory patients. Only
7% of the non-ambulatory patients regained ability to walk. None of the responders had bladder or
bowel dysfunction. Twenty-two percent of the responders are still ambulatory with a mean follow-up of
six months (JPMA 41: 60, 1991).
INTRODUCTION
Spinal cord compression (SCC) is one of the commonest neurologic complications seen in patients
suffering from cancer. At autopsy, its occurrence is documented in approximately 5% of patients with
malignancy1. SCC is an oncologic emergency because delay in recognition and without urgent
treatment, permanent neurologic damage may occur. SCC usually occurs in the setting of previously
diagnosed malignancy but a sizeable proportion (8% - 47%) may present with SCC as the initial
clinical manifestation of underlying cancer1-3. Management and the results of treatment depend upon
the duration of symptoms prior to the diagnosis, degree of neurologic deficit, promptness of
intervention, type of treatment and the underlying malignancy. At the Aga Khan University Hospital,
we performed a retrospective analysis of thirty-three patients with malignancy induced SCC. We
studied the clinical features, site of vertebral involvement, type of underlying malignancy, subsequent
management and survival. We also compared these data with the study from Memorial Hospital2.
PATIENTS AND METHODS
All patients developing SCC who had a prior diagnosis of cancer or those presenting with SCC in
whom malignancy was subsequently found to be the cause of SCC were eligible for this study. On a
pre-set format, .information was collected regarding the clinical features at the time of diagnosis.
Origin of the primary neoplasm was ascertained from review of the clinical findings and the available
pathologic material. Level of the cord compression was determined on the basis of clinical findings,
plain x-rays, CT scan and myelogram when available. Details of management, response to treatment
and follow-up data were obtained from the case records.

RESULTS
Thirty three patients were eligible for the study. The clinical features are presented in Table I.

Almost two-thirds of the patients were male. Median age was 42.8 years. Slightly more than half (52%)
presented with SCC as the initial manifestation of underlying malignancy; in the remainder it
developed after a mean interval of 11.8 months (range 0-5 years) after the original diagnosis of cancer.
Patients had symptoms related to SCC for an average of 4.5 months (range 1 day -2 years). Back pam
was the commonest finding. Sensory deficit and autonomic dysfunction were frequently observed
(45.5% each), whereas ataxia was uncommon (6%). Most of the patients (73%) were non-ambulatory
at the time of diagnosis. Level of spinal involvement was mainly thoracic (62%), followed by lumbar
(38%). One patient had compression at more than one site. Primary tumours causing SCC are listed in
Table II.

Breast cancer was the commonest cause of SCC in females. In males, lung and prostrate were
frequently encountered. The results of treatment are summarized in Table III.

Only eighty-two percent of the patients received treatment. Rest were felt to have SCC for too long a
time period to benefit from any treatment. Majority (85%) received steroids, followed by chemotherapy
(74%) and radiotherapy (33%). Decompression laminectomy was performed in fifteen percent of the
patients. Follow-up is available on 67% of patients, 22% of them are still fully ambulatory. Best results
were achieved in those who were ambulatory at the time of presentation and did not have bladder or
bowel dysfunction. Fifty percent of the patients who were ambulatory remained so, however only 9%
of the patients who were non-ambulatory were able to walk again. Of those who remained or regained
ambulatory status, none had bladder or bowel dysfunction. Seventy-two percent of the patients died
without resolution of SCC, 22% are alive and ambulatory, rest alive but non-ambulatory. The median
duration of follow-up is six months.

DISCUSSION
SCC can be a devastating neurologic complication of cancer. Delay in diagnosis and initiation of
therapy may result in jrreversible neurologic deficit 4. Hence early recognition and prompt intervention
is essential for a favourable clinical outcome. Autopsy studies indicate that approximately 5% of the
cancer patients develop extra-dural spinal metastases, many of them remain asym-ptomatic during
life1. Vast majority of the cases of SCC are caused by extra-dural rather than intra-medullary
compression of the spine2. Primary tumours causing SCC most commonly arise from lung, breast,
prostrate and kidney3. In this study, two-thirds of the patients were males. This is similar to Memorial
study2. However, our patients had a mean age of 42.8 years which is much lower than 58 years reported
in that study. Reason for this observation remain unknown although it may be related to lower life
expectancy. Almost half of our patients presented with SCC as compared to less than ten percent in the
Memorial study2. However, others have observed this mode of presentation in upto 47% of their
patients1,3. The earliest and the most important symptom of SCC is back pain. It has been observed in
96% of cases in the Memorial study2 and 97% of our patients. It precedes the onset of SCC by 7 weeks
to almost 7 months5. Hence the development of back pain in patients with cancer should be taken very
seriously and may possibly be an early indicator of SCC. Motor dysfunction (subjective or objective
weakness) was observed equally frequently in ours and Memorial studies2 (97% vs 87%). Distribution
of sensory dysfunction (45% vs 59%) and ataxia (6% vs 3%) is also very similar. Duration of the
symptoms due to SCC prior to the establishment of the diagnosis varied from 1 day to 2 years.
Similarly, time interval between the initial diagnosis of cancer and development of SCC varied from o
to 5 years, the longest interval was observed in patients with carcinoma of breast. Level of spinal
involvement waâthoracic in 62% and lumbar in 38% of the cases. In the Memorial series2 15% of the
blocks were cervical, 69% thoracic and 16% lumbosacral. Absence of cervical SCC in our series
remains unexplained although small size of this study and lower number of lung cancer patients may be
partly responsible for this finding. Commonest cause of SCC in our study is breast cancer which differs
from the Memorial study2. Since Aga Khan Hospital is not a radiation oncology centre and lung cancer
more often requires radiotherapy, the pattern of referral of patients may explain this difference. It would
be interesting to look at data from Jinnah Postgraduate Medical Centre, Karachi or other radiotherapy
centres in the country. Distribution of other tumours is quite similar to the Memorial study2. Outcome
of the treatment depends upon the degree of neurologic deficit already present and its duration prior to
the diagnosis6-10. Fifty percent of our patients who were ambulatory remained so for a period of 2
months to over one year. Only seven percent of the non-ambulatory patients became ambulatory (50%
vs 7%). This is similar to the Memorial study2 (60% vs 7%). Our study also demonstrates that
development of autonomic dysfunction is a poor prognostic factor and none of our patients with
bladder or bowel dysfunction responded to any measures. This has been shown in other studies as well
where two-thirds of the patients with autonomic dysfunction failed to achieve any benefit 4. This is in
marked contrast to those without autonomic dysfunction where more than fifty percent remain
ambulatory4. Steroids are commonly used for the SCC to decrease vasogenic edema in the compressed
cord11-14 and results in stabilization of the neurologic deficit. Decompression laminectomy may not
offer any additional advantage over radiotherapy alone2,11,15. Its role may be confined to the patients
who have received prior radiation, require a diagnostic procedure and those with pathologic
compression fracture, known radioresistant tumours (melanoma, sarcoma etc) or with destruction of the
spine by a paraspinous tumour. However, more recent introduction of vertebral body resection, tumour
excision and immediate stabilization of spine has shown excellent responses16-18. Most of our patients
had dense paraplegia at the time of diagnosis. Vast majority of these patients did not respond to steroids

and no radiotherapy was given. However, almost half of the ambulatory patients remained so after
treatment with steroids and radiotherapy. Twenty-two percent of our patients are still alive and
ambulatory with a mean follow-up of six months. In conclusion, malignancy induced SCC must be part
of the differential diagnosis ofa patient who presents with back pain and leg weakness. In those with
prior cancer, back pain is usually the earliest sign. The condition requires prompt diagnosis and early
intervention to prevent irreversible neurologic damage. Commonest tumour causing SCC is breast in
females and lung in males. If diagnosed early, and treatment started while the patient is still ambulatory,
the clinical outcome may be significantly improved.
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